Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03459690 · ClinicalTrials.gov registry record · NA
EEG Changes With Guided Online Meditation
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03459690: Completed NA study, sponsored by Beth Israel Deaconess Medical Center.
NCT03459690 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03459690, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Simple meditation and EEG changes
Primary Outcome
Number of participants who had EEGs to measure qualitative changes in wave oscillations
Interventions
- BEHAVIORAL Meditation
- DEVICE Enobio 32- EEG machine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-05-29 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
What the finished NCT03459690 record still lists
NCT03459690 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Meditation is the first listed.
NCT03459690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03459690 about?
NCT03459690 is a clinical study titled "EEG Changes With Guided Online Meditation". Simple meditation and EEG changes
What is the current status of trial NCT03459690?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2018-05-29. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT03459690?
The interventions under investigation include: Meditation (BEHAVIORAL), Enobio 32- EEG machine (DEVICE).
Who is sponsoring clinical trial NCT03459690?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03459690's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI